[HTML][HTML] Advances in the diagnosis and early management of gestational trophoblastic disease
CM Joyce, B Fitzgerald, TV McCarthy, J Coulter… - BMJ …, 2022 - ncbi.nlm.nih.gov
Gestational trophoblastic disease describes a group of rare pregnancy related disorders that
span a spectrum of premalignant and malignant conditions. Hydatidiform mole (also termed …
span a spectrum of premalignant and malignant conditions. Hydatidiform mole (also termed …
A biomimetic nanoreactor for combinational chemo/chemodynamic therapy of choriocarcinoma through synergistic apoptosis and ferroptosis strategy
Choriocarcinoma is a malignant tumor caused by aberrant proliferation and excessive
invasion of trophoblastic cells in the uterus. Treatment for choriocarcinoma is hampered by …
invasion of trophoblastic cells in the uterus. Treatment for choriocarcinoma is hampered by …
[HTML][HTML] From national to international collaboration in gestational trophoblastic disease: hurdles and possibilities
F Golfier, MJ Seckl - Gynecologic and Obstetric Investigation, 2024 - karger.com
Background: Today, most women with gestational trophoblastic disease (GTD) can expect to
be cured, particularly if they live in middle-to high-income countries with access to GTD …
be cured, particularly if they live in middle-to high-income countries with access to GTD …
Discovery, optimization, and evaluation of selective cdk4/6 inhibitors for the treatment of breast cancer
W Chen, M Ji, H Cheng, M Zheng, F Xia… - Journal of Medicinal …, 2022 - ACS Publications
Breast cancer is the most common tumor in women, and selective cyclin-dependent kinase
(CDK) 4/6 inhibitors played an important role in the treatment of breast cancer. Therefore …
(CDK) 4/6 inhibitors played an important role in the treatment of breast cancer. Therefore …
Pinostrobin and tectochrysin conquer multidrug-resistant cancer cells via inhibiting P-glycoprotein ATPase
Enhanced drug efflux through ATP-binding cassette transporters, particularly P-glycoprotein
(P-gp), is a key mechanism underlying multidrug resistance (MDR). In the present study, we …
(P-gp), is a key mechanism underlying multidrug resistance (MDR). In the present study, we …
Mosloflavone from Fissistigma petelotii ameliorates oncogenic multidrug resistance by STAT3 signaling modulation and P-glycoprotein blockade
Background Oncogenic multidrug resistance (MDR) is a tough question in cancer therapy.
However, no effective medications targeting oncogenic MDR are currently available. Studies …
However, no effective medications targeting oncogenic MDR are currently available. Studies …
[HTML][HTML] FOXM1 mediates methotrexate resistance in osteosarcoma cells by promoting autophagy: The role of FOXM1 in drug resistance in osteosarcoma
L Wang, D Zhai, L Tang, H Zhang… - Acta Biochimica et …, 2024 - pmc.ncbi.nlm.nih.gov
Osteosarcoma (OS) is a primary bone cancer mostly found in adolescents and elderly
individuals. The treatment of OS is still largely dependent on traditional chemotherapy …
individuals. The treatment of OS is still largely dependent on traditional chemotherapy …
Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targets
L McNally, S Wu, K Hodges, M Oberley… - Gynecologic …, 2024 - Elsevier
Objective The treatment for high risk or recurrent gestational trophoblastic neoplasia (GTN)
is a highly toxic multi-agent chemotherapy. For patients with progressive or recurrent GTN …
is a highly toxic multi-agent chemotherapy. For patients with progressive or recurrent GTN …
The role of cancer-associated fibroblasts in altering signal transduction and drug resistance in KRAS mutated cancers
R Lau - 2023 - repository.icr.ac.uk
KRAS is commonly mutated in solid tumours but effective treatment is limited due to
resistance. Cancer-associated fibroblasts (CAFs) are a key tumour microenvironment …
resistance. Cancer-associated fibroblasts (CAFs) are a key tumour microenvironment …